Domain-specific cognitive course in schizophrenia: Group- and individual-level changes over 10 years
- PMID: 35783460
- PMCID: PMC9240854
- DOI: 10.1016/j.scog.2022.100263
Domain-specific cognitive course in schizophrenia: Group- and individual-level changes over 10 years
Abstract
Cognitive impairments in schizophrenia are well-documented, present across several cognitive domains and found to be relatively stable over time. However, there is a high degree of heterogeneity and indications of domain-specific developmental courses. The present study investigated the 10-year cognitive course in participants with first-episode schizophrenia (FES) and healthy controls on eight cognitive domains and a composite score, looking at group- and individual-level changes. A total of 75 FES participants and 91 healthy controls underwent cognitive assessment at baseline and follow-up. Linear mixed models were used for group-level analyses and reliable change index (RCI) analyses were used to investigate individual change. The prevalence of clinically significant impairment was explored at both time points, using a cut-off of < -1.5 SD, with significant cognitive impairment defined as impairment on ≥2 domains. Group-level analyses found main effects of group and time, and time by group interactions. Memory, psychomotor processing speed and verbal fluency improved, while learning, mental processing speed and working memory were stable in both groups. FES participants showed deteriorations in attention and cognitive control. Individual-level analyses mainly indicated stability in both FES and controls, except for a higher prevalence of decline in cognitive control in FES. At baseline, 68.8 % of FES participants had clinically significant impairment, compared to 62.3 % at follow-up. We mainly found long-term stability and modest increases in cognition over time in FES, as well as a high degree of within-group heterogeneity. We also found indications of deterioration in participants with worse cognitive performance at baseline.
Keywords: Cognition; First-episode schizophrenia; Long-term cognitive development.
© 2022 The Authors.
Conflict of interest statement
The authors have no conflicts of interest to declare.
Figures




Similar articles
-
Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.Clin Ther. 2008 Sep;30(9):1565-89. doi: 10.1016/j.clinthera.2008.09.014. Clin Ther. 2008. PMID: 18840365 Review.
-
Cognitive improvement in first-episode schizophrenia and healthy controls: A 6-year multi-assessment follow-up study.Psychiatry Res. 2018 Sep;267:319-326. doi: 10.1016/j.psychres.2018.06.016. Epub 2018 Jun 18. Psychiatry Res. 2018. PMID: 29957548
-
Comparison of cognitive functions between first-episode schizophrenia patients, their unaffected siblings and individuals at clinical high-risk for psychosis.Psychol Med. 2019 Aug;49(11):1929-1936. doi: 10.1017/S0033291718002726. Epub 2018 Sep 18. Psychol Med. 2019. PMID: 30226125
-
Meta-analysis of cognitive function in Chinese first-episode schizophrenia: MATRICS Consensus Cognitive Battery (MCCB) profile of impairment.Gen Psychiatr. 2019 Jul 22;32(3):e100043. doi: 10.1136/gpsych-2018-100043. eCollection 2019. Gen Psychiatr. 2019. PMID: 31423473 Free PMC article.
-
Meta-analysis of Cognitive Impairment in First-Episode Bipolar Disorder: Comparison With First-Episode Schizophrenia and Healthy Controls.Schizophr Bull. 2015 Sep;41(5):1095-104. doi: 10.1093/schbul/sbu198. Epub 2015 Jan 23. Schizophr Bull. 2015. PMID: 25616505 Free PMC article. Review.
Cited by
-
Longitudinal course of inflammatory-cognitive subgroups across first treatment severe mental illness and healthy controls.Psychol Med. 2024 Oct 2;54(12):1-11. doi: 10.1017/S003329172400206X. Online ahead of print. Psychol Med. 2024. PMID: 39354711 Free PMC article.
-
Inflammation and cognition in severe mental illness: patterns of covariation and subgroups.Mol Psychiatry. 2023 Mar;28(3):1284-1292. doi: 10.1038/s41380-022-01924-w. Epub 2022 Dec 28. Mol Psychiatry. 2023. PMID: 36577840 Free PMC article.
-
The Combined Effects of EEG Biofeedback and Olanzapine on Glucose and Lipid Metabolism, Cardiac Function, and Cognitive Function in Patients With Schizophrenia.Actas Esp Psiquiatr. 2025 May;53(3):570-577. doi: 10.62641/aep.v53i3.1823. Actas Esp Psiquiatr. 2025. PMID: 40356004 Free PMC article.
-
Seasonality of brain function: role in psychiatric disorders.Transl Psychiatry. 2023 Feb 22;13(1):65. doi: 10.1038/s41398-023-02365-x. Transl Psychiatry. 2023. PMID: 36813773 Free PMC article. Review.
-
Cognitive change 5+ years since the onset of a psychotic disorder: A systematic review and meta-analysis.Psychol Med. 2025 Jul 16;55:e198. doi: 10.1017/S0033291725100627. Psychol Med. 2025. PMID: 40665818 Free PMC article.
References
-
- Albus M., Hubmann W., Mohr F., et al. Neurocognitive functioning in patients with first-episode schizophrenia: results of a prospective 15-year follow-up study. Eur. Arch. Psychiatr. Clin. Neurosci. 2019;256(7):442–451. - PubMed
-
- Ammari N., Heinrichs R.W., Miles A.A. An investigation of 3 neurocognitive subtypes in schizophrenia. Schizophr. Res. 2010;121(1–3):32–38. - PubMed
-
- Bergh S., Hjorthøj C., Sørensen H.J., Fagerlund B., Austin S., Secher R.G. Predictors and longitudinal course of cognitive functioning in schizophrenia spectrum disorders, 10 years after baseline: the OPUS study. Schizophr. Res. 2016;175(1–3):57–63. - PubMed
-
- Blair J.R., Spreen O. Predicting premorbid IQ: a revision of the national adult reading test. Clin. Neuropsychol. 1989;3(2):129–136.
LinkOut - more resources
Full Text Sources
Miscellaneous